When: Confirmed close >$213.97 on volume ≥7M with contracting MACD histogram AND positive RSI divergence

Then: Upgrade to Overweight

When: Weekly close <$190 with 200 SMA slope flattening

Then: Sell/Full exit

HOLD - maintain existing positions but do not add fresh risk; wait for technical confirmation (daily close above 10 EMA at 207.81 on expanding volume) before any new exposure; trim if daily close below 200 SMA on expanding volume

• Asymmetry math is flawed: downside to 200 SMA is not a clean 5.5%, but could open to 10-15% drawdown if structure breaks
• Distribution volume of 7-9M shares on consecutive red days vs 3-5M baseline suggests conviction selling, not institutional rebalancing
• Hammer pattern at lower band is unconfirmed (no next-session bullish candle) and has ~50% failure rate
• Resistance stack at 207-213 represents real overhead supply from recent buyers' cost basis, not just moving averages
• Goldman trading weakness may be a leading indicator for broader capital markets deceleration; MS relative strength today could become a momentum trap
• 95% probability of no rate cuts creates crowded consensus fragility; surprise dovishness would reprice long-duration assets
• 10-year yield near 5% suppresses capital markets activity (~40% of MS revenue), creating a corresponding headwind to NII tailwind
• Forward P/E of 14.85 is not a floor in a contracting multiple regime with above-market beta (1.21) and rolling momentum
• 2.26% dividend yield provides carry but takes over a year to recover a 10% principal loss
• Discipline of waiting for confirmation protects capital; catching falling knives for a living is how drawdowns accumulate

→ vs aggressive: Upside target anchored to 50 SMA at 214 ignores that it coincides with Bollinger middle band and rolling-over overhead resistance requiring sustained buying pressure that hasn't been demonstrated

→ vs aggressive: Hammer pattern thesis is anchoring to a single unconfirmed candlestick with ~50% failure rate; without next-session bullish confirmation, it's just a pause that refreshes sellers

→ vs aggressive: Distribution volume (7-9M shares on red days vs 3-5M baseline) is conviction distribution, not institutional rebalancing; institutions use dark pools and worked orders over weeks, not consecutive high-volume down days

→ vs aggressive: Goldman trading softness is not cleanly priced in through a single session; sector-wide weakness typically shows relative strength before rolling over as fundamental pressure catches up

→ vs aggressive: 95% probability of no rate cuts is crowded consensus fragility, not tailwind; 10-year near 5% suppresses capital markets (~40% of revenue) while supporting NII, and these cannot simply be netted out

→ vs aggressive: 14.85 forward earnings is not a gift when multiples are contracting; a low multiple in this regime can quickly become 12-13 on Q3 disappointment or sector credit event

→ vs aggressive: Waiting for confirmation is not performance anxiety; it's the discipline that prevents owning names that break structure and keep falling

HOLD with active conditional framework: maintain current exposure, do not add at $202.58, define starter-buy zone at $185-190 sized to 3% portfolio, define trim trigger at daily close below $200 on expanding volume

• Fundamentals support continued ownership — 18% ROE, 62% EPS growth, record quarters, $1.67B quarterly buybacks, 2.26% dividend yield, 14.85 forward P/E for growth profile is reasonable
• Technical structure warrants patience for new capital — current setup doesn't justify adding at $202.58
• Realistic upside is 8-12% (multiple resistance layers: 50 SMA, Bollinger middle band, upper band at $222)
• Realistic downside is 5-13% (worst case gap-fill zone at $175-180 if 200 SMA breaks)
• 3% starter position in $185-190 zone is appropriately calibrated to probability of bounce at major support
• Hammer candle at support confluence (lower Bollinger, 200 SMA, multi-month uptrend line, RSI 35.55) increases bounce probability above 50%
• Binary buy-or-trim framing is the core error — data supports probabilistic, scaled approach
• Capital markets sector showing internal weakness — diversify rather than concentrate
• Q3 earnings in late October could resolve technical setup without requiring full retest of support
• 200 SMA break on expanding volume is the structural line where fundamental thesis breaks down

→ vs aggressive: Asymmetry math is cherry-picked — real downside is 10-13%, not 5.5%, because confirmed 200 SMA break opens gap-fill zone to $175-180; upside requires clearing three layers of overhead supply, not just one

→ vs aggressive: Volume distribution reinterpretation as 'rebalancing' is weakest part of argument — institutions can and do hit bid on multiple sessions during risk-off rotations and sector de-risking events

→ vs aggressive: Relative strength vs Goldman and Lazard isn't true bullish divergence — MS is making lower lows alongside peers, just less aggressively; that's slower decay, not divergence

→ vs aggressive: Long-term fundamental quality and short-term tactical entry are two different problems — conflating them leads to buying at wrong price and wrong time

→ vs conservative: Base case 'chop' framing is too pessimistic — stocks at lower Bollinger band at major moving average support with hammer statistically resolve directionally within 5-10 sessions, not extend sideways

→ vs conservative: Hammer dismissal is strategically incomplete — ignoring support confluence across multiple technical indicators shifts bounce probability meaningfully above 50%

→ vs conservative: Macro framing is contradictory — cannot simultaneously argue recession is unlikely at 8% odds AND that macro setup is bearish; must pick one

→ vs conservative: Multiple re-rating from 14.85 to 12-13 requires fundamental break or regime change, neither is base case with two consecutive record quarters

→ vs conservative: Confirmation bar is set too high — demanding two consecutive sessions of RS against XFL borders on paralysis; single close above 10 EMA at $207.81 with volume and MACD confirmation is sufficient